Clinical trial
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
NCT02411084 is registered in ClinicalTrials.gov with Adienne SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
- Lead sponsor
- Adienne SA
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- February 29, 2016
- Completion date
- July 31, 2017
- Enrollment
- 36 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.